AwardedSpainGoods€15,106,505
2o Contrato basado en el AM 111/2022 para el suministro de enzimas, medicamentos huérfanos y para el tratamiento de enfermedades raras
- Published
- Published 27 May 2026
Overview
Suministro de forma centralizada de medicamentos de uso humano enzimas, medicamentos huérfanos y para el tratamiento de enfermedades raras en el ámbito de la sanidad pública valenciana.
Key details
- Country
- Spain
- Status
- Awarded
- Category
- Goods
- Estimated value
- €15,106,505
- Procedure
- Direct
- Published
- 27 May 2026
Medicinal products for the alimentary tract and metabolismVitaminsMedicinal products for the musculo-skeletal systemAntimycotics for systemic useAntimycobacterialsAntineoplastic and immunomodulating agentsImmunosuppressive agentsOther nervous system medicinal products
Award outcome
- Awarded value
- €58,239,932
- Award date
- 8 July 2025
- ACCORD HEALTHCARE S.L.U.
- ALNYLAM PHARMACEUTICALS SPAIN SL
- AUROVITAS SPAIN, S.A.U.
- BIOGEN SPAIN, S.L.
- EUROCEPT INTERNATIONAL B.V
- IMMEDICA PHARMA IBERIA, S.L.
- OTSUKA PHARMACEUTICAL, S.A.
- PFIZER, S.L.U.
- SANOFI AVENTIS, S.A.
- TAKEDA FARMACÉUTICA ESPAÑA S.A.
Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.
Notice history
Every published notice in this contracting process, newest first.
Contract Award Notice
27 May 2026
Contracting authority
Dirección General de Gestión Económica, Contratación e Infraestructuras de la Conselleria de Sanidad
Procuring entityValencia, Spain
ID_PLATAFORMA: 20897030133463
Get the full picture
AI analysis, bid scoring, and expert strategy for this tender
Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.
See which competitors are winning the contracts you're chasing.
15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.